style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%">
August 17, 2021
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
100 F Street, NE
Washington, D.C. 20549
Attn: Heather Clark/Thomas Jones
Dear Ms. Clark/Mr. Jones:
Pursuant to Rule 259 under the Securities Act of 1933, as amended (the “
”), SOBR Safe, Inc. (the “
”) hereby requests that the Securities and Exchange Commission (the “
”) consent to the withdrawal of the above-referenced offering statement (the “
”). The Company has been presented with what it believes may be more attractive financing options and, as a result, has decided not to pursue a Regulation A exempt offering at this time.
As of the date hereof, the offering has not yet been qualified and none of the securities subject to the Offering Statement have been sold. Additionally, the Offering Statement is not the subject of a suspension of exemption proceeding under Rule 258 of the Act.
Accordingly, we hereby request that the Commission consent to the withdrawal of the Offering Statement with an order granting the withdrawal as of the date of the filing for this request. Should the staff of the Commission have further questions regarding this request, please contact the Company’s corporate and securities counsel, Craig V. Butler, Esq. of The Law Offices of Craig V. Butler at (949) 484-5667 or email@example.com, or the undersigned at (844) 762-7723 or firstname.lastname@example.org. Please provide the undersigned and the Company’s counsel with a copy of the order granting withdrawal of the Offering Statement as soon as it is available.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever TransBiotec, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
TransBiotec, Inc. director just picked up 11,765 shares - June 21, 2022
TransBiotec, Inc. director just declared ownership of no shares of TransBiotec, Inc. - June 15, 2022
TransBiotec, Inc.'s CFO just declared ownership of no shares of TransBiotec, Inc. - June 13, 2022
TransBiotec, Inc.'s CFO just picked up 11,765 shares - June 13, 2022